QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2013     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15 作者:  Tan, Fenlai;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang;  Wang, Chang-Li 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15 作者:  Tan, Fenlai;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang;  Wang, Chang-Li 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial 期刊论文 The Lancet Oncology, 2013, 卷号: 14, 期号: 10, 页码: 953-961 作者:  Shi, Yuankai*;  Zhang, Li;  Liu, Xiaoqing;  Zhou, Caicun;  Zhang, Shucai 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/03 Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial 期刊论文 LANCET ONCOLOGY, 2013, 卷号: 14, 期号: 10 作者:  Shi, Yuankai;  Zhang, Li;  Liu, Xiaoqing;  Zhou, Caicun;  Zhang, Li 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19 Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial 期刊论文 2013, 卷号: 14, 期号: 10, 页码: 953-961 作者:  Shi, Yuankai;  Zhang, Li;  Liu, Xiaoqing;  Zhou, Caicun;  Zhang, Shucai 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/13 Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20 作者:  Tan, Fenlai;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang;  Wang, Chang-Li 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13 Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study. 期刊论文 2013, 卷号: 31, 期号: 15 作者:  Tan, Fenlai;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang;  Wang, Chang-Li 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13